Levetiracetam and Valproic Acid: Effects on the Liver Functions and Ammonia Level in Children

Purpose: There is evidence that levetiracetam and valproic acid causes a changes of serum ammonia level and liver function tests. The aim of this study was to evaluate the liver function parameters and ammonia level in children with seizures on treatment with levetiracetam in comparison treated with...

Full description

Bibliographic Details
Published in:	Çukurova Üniversitesi Tıp Fakültesi Dergisi
Main Authors:	Faruk Incecik, M. Ozlem Herguner, Sakir Altunbasak
Format:	Article
Language:	English
Published:	Cukurova University 2014-02-01
Subjects:	Levetiracetam valproic acid liver functions ammonia
Online Access:	http://www.scopemed.org/fulltextpdf.php?mno=41830

Similar Items

Controlled Evaluation of Serum Lipid Levels and Carotid Artery Intima Media Thickness in Epileptic Children Treated with Valproic Acid, Carbamazepine and Levetiracetam
by: Betül AKSOY, et al.
Published: (2024-12-01)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
by: Cheng-Yen Kuo, et al.
Published: (2020-04-01)

Impact of Valproate and Levetiracetam Exposure on GAERS Behavior During Pregnancy
by: Melis Yavuz, et al.
Published: (2023-09-01)

Ammonia Blood Levels and Valproic Acid
by: J Gordon Millichap
Published: (2007-12-01)

Chronic Valproic Acid Administration Increases Plasma, Liver, and Brain Ammonia Concentration and Suppresses Glutamine Synthetase Activity
by: Abdelnaser A. Badawy, et al.
Published: (2020-10-01)

Urinary and fecal incontinence during levetiracetam therapy
by: Faruk Incecik, et al.
Published: (2015-01-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Comparison of effects and electrophysiological mechanisms of action of valproic acid and levetyracetam in an experimental model of focal epilepsy
by: Svetlana A. Litvinova, et al.
Published: (2018-10-01)

Valproic Acid-Induced Hyperammonemic Encephalopathy in a Patient with Bipolar Disorder: A Case Report
by: Meng-Yu Wu, et al.
Published: (2020-03-01)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009-06-01)

Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)

Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature
by: Andreas Rogalewski, et al.
Published: (2021-01-01)

Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)

Chronic histopathological effects of levetiracetam on some internal organs of adult albino rats
by: Huda A.M. Omer, et al.
Published: (2015-06-01)

Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996-08-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

TICS IN CHILDREN. CLINICAL RESULT OF THE TREATMENT TIC DISORDERS BY LEVETIRACETAM
by: Ju. V. Borodina, et al.
Published: (2016-05-01)

Comparative analysis of brivaracetam and levetiracetam in epilepsy treatment
by: Ming-Yuan Hsu, et al.
Published: (2025-01-01)

Síndrome de DRESS asociado a Levetiracetam
by: Moreno Díaz J, et al.
Published: (2016-09-01)

Hallucination: A rare complication of levetiracetam theraphy
by: Seher Erdogan, et al.
Published: (2017-11-01)

Multifocal myoclonus as a presentation of levetiracetam toxicity
by: Mei Bou Nasif, et al.
Published: (2021-01-01)

Evaluation of sixteen children with pseudotumor cerebri
by: Faruk Incecik, et al.
Published: (2011-02-01)

Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
by: Sophia Westphal, et al.
Published: (2021-05-01)

Hypohidrosis and hyperthermia during topiramate treatment in children
by: Faruk Incecik, et al.
Published: (2012-10-01)

Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002-06-01)

Valproic Acid and Sleep Duration in Children with Epilepsy
by: J Gordon Millichap
Published: (2009-09-01)

Phenytoin Versus Levetiracetam for Post-traumatic Seizure Prophylaxis
by: Tuğçe Mengi, et al.
Published: (2022-12-01)

A case of glossopharyngeal neuralgia successfully treated with levetiracetam
by: Hiroyuki Nishie, et al.
Published: (2023-02-01)

Protective role of vitamin E against valproic acid-induced cytogenotoxicity and hepatotoxicity in mice
by: Ehab M. Abdella, et al.
Published: (2014-08-01)

Evaluation of Hemogram Indices of Children with Epilepsy Receiving Short-Term Levetiracetam Treatment
by: Turgay Çokyaman, et al.
Published: (2022-09-01)

Strategies to innovate emergency care of status epilepticus
by: Jaideep Kapur
Published: (2025-01-01)

The strategy for enhancing temozolomide against malignant glioma
by: Mitsutoshi eNakada, et al.
Published: (2012-08-01)

Hepatic Fatalities and Valproic Acid
by: J Gordon Millichap
Published: (1996-04-01)

Valproic Acid-induced Agranulocytosis
by: Hui-Chuan Hsu, et al.
Published: (2009-06-01)

Effect of Levetiracetam on Motor Learning
by: J Gordon Millichap
Published: (2003-01-01)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018-04-01)

Severe Valproic Acid Intoxication Responding to Hemodialysis
by: Ali Ertuğ Arslanköylü, et al.
Published: (2017-08-01)

Current Views on the Use of Valproic Acid in Women
by: Kezban ASLAN KARA, et al.
Published: (2019-08-01)

Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid
by: Masazumi Ando, et al.
Published: (2017-07-01)